Now is the time to push back the progression of ADPKD with JYNARQUE® (tolvaptan)
Talk to your nephrologist and learn how JYNARQUE is proven to slow kidney function decline in adults who are at risk for rapidly progressing ADPKD.
ADPKD=autosomal dominant polycystic kidney disease.
How is your ADPKD PROGRESSING?
How is your ADPKD PROGRESSING?
ADPKD progression looks different for everyone. Do you know if you are at risk of rapidly progressing ADPKD or if your ADPKD is already rapidly progressing? It's important that you work with your nephrologist to understand your risk for rapid progression. The sooner you start, the sooner you can help take control of your ADPKD.
Treating your ADPKD
Treating your ADPKD
For adults who are at risk for rapidly progressing ADPKD, JYNARQUE is the only FDA-approved treatment proven to work over a period of years to slow the decline of kidney function.
Connect with the ADPKD community
Connect with the ADPKD community
You are not alone. Over 10,000 people have been prescribed and have taken JYNARQUE. Hear real stories from the first generation at risk for rapidly progressing ADPKD with a treatment to call their own.
SAVE on your JYNARQUE
SAVE on your JYNARQUE
Eligible patients pay as little as $10 per month for a JYNARQUE prescription*
Start slowing your disease progression with
* Assumes one 28-day supply prescription per month. If more than one prescription is filled in a calendar month, patient may pay more than $10 in that month. Offer is not transferable. Patients are not eligible if they are under 18 years of age or are covered in whole or in part by any state program or federal healthcare program, including, but not limited to, Medicare or Medicaid (including Medicaid managed care), Medigap, VA, DOD, or TRICARE. Only valid in US and Puerto Rico. Offer void where prohibited by law, taxed, or restricted. Other restrictions may apply. This program is not health insurance. Otsuka America Pharmaceutical, Inc. has the right to rescind, revoke, or amend this program at any time without notice. Your participation in this program confirms that this offer is consistent with your insurance coverage and that you will report the value received if required by your insurance provider. When you use this program, you are certifying that you understand and will comply with the program rules, terms, and conditions.